COVID conspiracy meets science as controversial bill targets virus research
Share- Nishadil
- January 13, 2024
- 0 Comments
- 2 minutes read
- 35 Views
A recent hearing in Wisconsin has ignited a fiery debate, pitting lawmakers against scientists over a proposed ban on research that could enhance the dangerousness of human pathogens. While controversial, this "gain of function" (GOF) research forms a crucial part of understanding and preparing for future pandemics.
As reported by the , the , championed by a vocal minority, fuels the flames of the " " theory, suggesting the originated from a research mishap. Gigi Kwik Gronvall, a biosecurity expert at Johns Hopkins University, warns, "This bill will create uncertainty, deterring crucial research needed to be pandemic ready." While good intentions pave the road to hell, she emphasizes, "This path won't stop pandemics or prevent lab accidents." The 2011 H5N1 bird flu research, funded by the National Institutes of Health (NIH), remains etched in memory.
Modifying the virus for easier ferret transmission, though intended for pandemic preparedness, raised concerns about accidental lab leaks. This uproar led to a 2017 US policy requiring stricter reviews for federally funded studies. Florida became the first state to enact a GOF ban, but its narrow scope left it practically toothless.
However, Wisconsin's proposed AB431 aims to cut off state funding for institutions conducting ePPP research, effectively banning it within the state. Its sponsor, Assembly Representative Elijah Behnke, asserts, "Playing with dangerous pathogens comes at a cost. The science isn't worth the risk." Critics decry the bill's expansive definition of pandemic worthy pathogens, fearing it could encompass even common cold viruses.
The University of Wisconsin–Madison and the Medical College of Wisconsin warn, "This would significantly hinder research on human, plant, and animal pathogens, jeopardizing public health." Justin Kinney, a proponent of the lab leak theory and co founder of Biosafety Now, proposes a narrower ePPP definition targeting specific high risk pathogens and a single lab: Yoshihiro Kawaoka's at UW–Madison.
Behnke remains open to the change, acknowledging, "We are more than open to revisions." With Wisconsin's Democratic governor unlikely to sign the bill and Texas delaying action till 2025, the spotlight shifts to the federal IP policy. Congress demanded its completion by 2023, but its release remains to be determined.
Microbiologists hold their breath, hoping for a solution that balances pandemic preparedness with responsible research..